Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity.
Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity.
复制标题
DOI:
10.3390/v13061081
复制
发表时间:
2021-06-05
期刊:
影响因子:
--
通讯作者:
Berdnikovs S
中科院分区:
文献类型:
--
作者:
Coden ME;Loffredo LF;Abdala-Valencia H;Berdnikovs S
Epithelial characteristics underlying the differential susceptibility of chronic asthma to SARS-CoV-2 (COVID-19) and other viral infections are currently unclear. By revisiting transcriptomic data from patients with Th2 low versus Th2 high asthma, as well as mild, moderate, and severe asthmatics, we characterized the changes in expression of human coronavirus and influenza viral entry genes relative to sex, airway location, and disease endotype. We found sexual dimorphism in the expression of SARS-CoV-2-related genes ACE2, TMPRSS2, TMPRSS4, and SLC6A19. ACE2 receptor downregulation occurred specifically in females in Th2 high asthma, while proteases broadly assisting coronavirus and influenza viral entry, TMPRSS2, and TMPRSS4, were highly upregulated in both sexes. Overall, changes in SARS-CoV-2-related gene expression were specific to the Th2 high molecular endotype of asthma and different by asthma severity and airway location. The downregulation of ACE2 (COVID-19, SARS) and ANPEP (HCoV-229E) viral receptors wascorrelated with loss of club and ciliated cells in Th2 high asthma. Meanwhile, the increase in DPP4 (MERS-CoV), ST3GAL4, and ST6GAL1 (influenza) was associated with increased goblet and basal activated cells. Overall, this study elucidates sex, airway location, disease endotype, and changes in epithelial heterogeneity as potential factors underlying asthmatic susceptibility, or lack thereof, to SARS-CoV-2.
登录
查看更多内容
影响因子:
6.7
作者:
Hatesuer B;Bertram S;Mehnert N;Bahgat MM;Nelson PS;Pöhlmann S;Schughart K
通讯作者:
Schughart K
影响因子:
4.4
作者:
Van Bever, HP;Chng, SY;Goh, DY
通讯作者:
Goh, DY
DOI:
10.1016/j.jaci.2017.04.010
发表时间:
2017-06
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
Schleimer RP;Berdnikovs S
通讯作者:
Berdnikovs S
DOI:
10.1164/rccm.202003-0821oc
发表时间:
2020-07-01
影响因子:
24.7
作者:
Peters, Michael C.;Sajuthi, Satria;Fahy, John, V
通讯作者:
Fahy, John, V
DOI:
10.1164/rccm.202003-0541oc
发表时间:
2020-07-15
影响因子:
24.7
作者:
Zhang, Haijun;Rostami, Mahboubeh R.;Crystal, Ronald G.
通讯作者:
Crystal, Ronald G.